Neuraltus Pharmaceuticals' Series B Round

Neuraltus Pharmaceuticals raised a round of funding on April 05, 2016.

Neuraltus Pharmaceuticals is a privately-held biopharmaceutical company dedicated to developing and commercializing innovative therapeutics that address critical unmet needs for patients and physician…

Articles about Neuraltus Pharmaceuticals' Series B Round: